1.0420
-0.0140
(-1.33%)
At close: January 31 at 9:55:02 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 1 | 3 | 4 |
| Avg. Estimate | 11.1M | 2M | 17.8M | 19.57M |
| Low Estimate | 2.88M | 2M | 9.57M | 12.2M |
| High Estimate | 26.54M | 2M | 33.23M | 39.46M |
| Year Ago Sales | 1.69M | 1.71M | 19.05M | 17.8M |
| Sales Growth (year/est) | 556.67% | 16.89% | -6.57% | 9.96% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| R3X1.F | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/12/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 10/23/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/15/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 8/14/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 5/13/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/13/2024 |
Related Tickers
196170.KQ ALTEOGEN Inc.
371,500.00
+2.62%
XENE Xenon Pharmaceuticals Inc.
39.98
-1.21%
FOLD Amicus Therapeutics, Inc.
9.58
-0.62%
MGNX MacroGenics, Inc.
3.0000
-0.33%
ADCT ADC Therapeutics SA
1.6800
-2.33%
EYPT EyePoint Pharmaceuticals, Inc.
7.65
-4.97%
ANNX Annexon, Inc.
3.8400
-4.95%
VYGR Voyager Therapeutics, Inc.
5.45
-2.85%
OCUL Ocular Therapeutix, Inc.
7.70
-1.03%
RNA Avidity Biosciences, Inc.
32.93
+0.92%